SCHEMBL22110735

SCHEMBL22110735

O=c1ccn([C@H]2CCC(CO)O2)c(=O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SLC28A1 O00337 1/20 0.52
▸ SLC28A2 O43868 1/20 0.52
▸ SLC29A1 Q99808 1/20 0.52
▸ SLC28A3 Q9HAS3 1/20 0.52
▸ ABL1 P00519 1/20 0.46
▸ RIN1 Q13671 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ ALB P02768 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ DUT P33316 3/20 0.43
▸ P2RY2 P41231 7/20 0.41
▸ P2RY6 Q15077 4/20 0.39
▸ P2RY4 P51582 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30007720 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL28067259 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL543110 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL22110849 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL23254274 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL8715 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL23254269 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL10349394 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
SCHEMBL24695426 1.00 SLC28A1 (0.52) SLC28A1SLC28A2SLC29A1SLC28A3ABL1
Hydrochloric Acid SCHEMBL27275372 0.99 SLC28A1 (0.51) SLC28A1SLC28A2SLC29A1SLC28A3ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013340-B1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN BIOPHARMA INC (US) 2023-06-07 — — EP disclosed
EP-3131914-B1 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV IDENIX PHARMACEUTICALS LLC (US) 2023-05-10 — — EP disclosed
WO-2021137913-A2 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO EMORY UNIVERSITY (US) 2021-07-08 — — WO disclosed
EP-3183261-B1 2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES GILEAD SCIENCES INC (US) 2020-06-17 — — EP disclosed
Send feedback